MIRAILAB BIOSCIENCE Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has partnered with Global Ocean Distribution Pte Ltd (Headquarters: Circular Road; Director: Getty Poon) to introduce its premium supplement brand MIRAI LAB, which features β-Nicotinamide Mononucleotide (β-NMN), to the Singapore market.…
Peter Hinchliffe, CEO of MedLumics, stated, “This marks a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system, utilizing Pulsed Field Ablation (PFA) and Optical Coherence Reflectometry (OCR) to monitor and confirm ablation success in real-time under direct…
A recent survey commissioned by Weave (NYSE: WEAV) sheds light on how patients across different generations are increasingly turning to the internet for health-related information and how this influences their interactions with healthcare providers. The study, conducted among 1,000 U.S.-based…
Sorriso Pharmaceuticals, a biopharmaceutical company focused on developing novel oral antibodies for immune-mediated diseases, today announced positive results from its Phase 1b clinical trial of SOR102. This oral, dual-acting biologic targets TNFα and IL-23 and was tested in patients with…
Uno Health, a service aimed at increasing access to benefits and savings for lower-income Americans, has launched the Uno Savings Guide. This free tool helps individuals of all ages, including Medicare and Medicaid recipients, by determining eligibility for financial benefit…
FlexIt, a leader in virtual fitness and wellness, is excited to announce the launch of FlexTogether™, a groundbreaking platform designed to connect individuals globally through innovative wellness experiences. This new initiative features FlexIt’s proprietary AI Class Creator™ Technology, which enhances…
Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is excited to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In this key role, Jacques will spearhead the development and execution…
LimmaTech Biologics AG, a clinical-stage biotech company focused on developing vaccines for life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its multivalent toxoid vaccine candidate, LBT-SA7. The vaccine is designed…
Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™, at two centers in Australia. The trial aims to evaluate…
Axoft, a neurotechnology company, has announced the approval of its first-in-human clinical study, set to begin in early 2025 at The Panama Clinic. The study will explore the usability of Axoft’s innovative soft materials, which mimic the mechanical properties of…
SV Health Investors, a prominent healthcare-focused private equity firm, is excited to announce the promotion of A.J. Rossi to Partner on its Growth-Buyout team. In this role, A.J. will continue to lead investments, oversee the SV portfolio, and contribute to…
COTA Inc., a leader in real-world data (RWD) and analytics for oncology, has announced a new partnership with precision oncology company Guardant Health Inc. (Nasdaq: GH). This collaboration will provide biopharmaceutical researchers with access to COTA’s research-grade electronic health record…